Table 4 Number of studies per year, and the techniques approach, and sequencing platforms
Year | Technique | Platform | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amplicon | WGS | Transcriptomics | Not Specified | 454 Roche s. 2005 | Applied biosystems s. 2007 | Illumina s. 2007 | Ion Torrent s. 2010 | Life technologies s. 2007 | Nanopore s. 2014 | Takara s. 2003 | Not specified | |
2003 | 2 | 0 | 0 | NA | NA | NA | NA | NA | NA | 0 | 2 | |
2004 | 0 | 0 | 0 | 1 | NA | NA | NA | NA | NA | NA | 0 | 1 |
2005 | 1 | 0 | 0 | 0 | NA | NA | NA | NA | NA | NA | 0 | 1 |
2006 | 0 | 0 | 0 | 0 | 0 | NA | NA | NA | NA | NA | 0 | 0 |
2007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NA | 0 | NA | 0 | 0 |
2008 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | NA | 0 | NA | 0 | 0 |
2009 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | NA | 0 | NA | 0 | 3 |
2010 | 3 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | NA | 0 | 2 |
2011 | 7 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | NA | 0 | 4 |
2012 | 8 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | NA | 1 | 7 |
2013 | 11 | 0 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | NA | 0 | 8 |
2014 | 9 | 2 | 0 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 13 |
2015 | 20 | 3 | 2 | 1 | 1 | 0 | 7 | 1 | 1 | 0 | 0 | 16 |
2016 | 36 | 1 | 0 | 1 | 1 | 2 | 7 | 2 | 0 | 0 | 0 | 24 |
2017 | 44 | 2 | 0 | 2 | 3 | 0 | 12 | 3 | 0 | 0 | 0 | 30 |
2018 | 60 | 6 | 0 | 2 | 0 | 1 | 22 | 1 | 5 | 0 | 0 | 40 |
2019 | 57 | 8 | 0 | 2 | 1 | 3 | 24 | 2 | 0 | 0 | 0 | 40 |
2020 | 75 | 9 | 0 | 8 | 0 | 2 | 42 | 1 | 3 | 0 | 0 | 44 |
2021 | 92 | 10 | 1 | 2 | 0 | 2 | 55 | 1 | 1 | 2 | 1 | 43 |
2022 | 33 | 12 | 0 | 0 | 0 | 2 | 31 | 0 | 1 | 0 | 0 | 9 |
Total | 462 | 53 | 4 | 26 | 9 | 20 | 203 | 11 | 11 | 2 | 2 | 287 |